openPR Logo
Press release

Pigmented Villonodular Synovitis Drug Market Will Generate Record Revenue by 2029

12-05-2023 10:02 AM CET | Health & Medicine

Press release from: Orion Market Research

Pigmented Villonodular Synovitis Drug Market Will Generate

Pigmented villonodular synovitis drug market is anticipated to grow at a significant CAGR during the forecast period. Pigmented villonodular synovitis (PVNS) is a joint problem that affects the hip or knee and causes the lining of a joint to be swollen and grow which harms the bone around the joint. However, it can also occur in the shoulder, ankle, elbow, hand or foot. The major factor driving the growth of the market is the increasing number of in-patients in hospitals suffering from rare conditions and growing demand for advanced treatment across the globe. Moreover, the market is also growing due to the increasing incidence of PVNS disease. According to the National Center for Biotechnology Information (NCBI), PVNS is a rare disease with a prevalence of 9.2 patients out of a million population. 

Some major players operating in the market include Bristol-Myers Squibb Co., Daiichi Sankyo Co., Ltd., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2019, Daiichi Sankyo Co., Ltd. announced the approval of TURALIO (pexidartinib) from the US Food and Drug Administration (FDA). It is the first and only treatment for symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery in adult patients. TGCT is also called pigmented villonodular synovitis (PVNS).

To Request a Sample of our Report on Pigmented Villonodular Synovitis Drug Market:  https://www.omrglobal.com/request-sample/pigmented-villonodular-synovitis-drug-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Type
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Bristol-Myers Squibb Co., Daiichi Sankyo Company, Ltd., and Novartis International AG, among others.

A full Report of Pigmented Villonodular Synovitis Drug Market is Available @ https://www.omrglobal.com/industry-reports/pigmented-villonodular-synovitis-drug-market

Pigmented Villonodular Synovitis Drug Market Report by Segment

By Type

Cabiralizumab
Emactuzumab
Mcs-110
Nilotinib
Others

By Application 

Clinic
Hospital
Homecare

Pigmented Villonodular Synovitis Drug Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pigmented Villonodular Synovitis Drug Market Will Generate Record Revenue by 2029 here

News-ID: 3315520 • Views:

More Releases from Orion Market Research

Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033
Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Fo …
In 2024, the global Mobile Gamma Cameras Market was valued at approximately USD 57.8 million, and it is expected to reach USD 79.2 million by 2033, reflecting a compound annual growth rate (CAGR) of around 3.39% between 2025 and 2033. Mobile Gamma Cameras Market Overview The Mobile Gamma Cameras Market is seeing steady growth, with demand rising across oncology, cardiology, and nuclear medicine due to its ability to provide portable,
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare Services AG, Osstem Implant, BioHorizons, MIS Implants Technologies
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare …
In 2024, the global Dental Implants Market was valued at approximately USD 6.8 billion, and it is projected to reach USD 9.8 billion by 2033, representing a compound annual growth rate (CAGR) of around 4.2% from 2025 to 2033. Dental Implants Market Overview The Dental Implants Market is experiencing robust growth driven by rising global incidences of tooth loss, heightened demand for aesthetic and permanent dental solutions, and rapid technological advancements-such
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dickinson and Company (BD), PerkinElmer Inc., Merck KGaA
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dic …
In 2024, the global Cell-based Assays Market is estimated at approximately USD 24.1 billion, and it is forecast to reach USD 45.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 6.9% from 2025 to 2033. Cell-based Assays Market Overview The Cell-based Assays Market is witnessing sustained growth driven by increased demand from drug discovery, disease modeling, and safety/toxicity testing. These assays-crucial in early-stage pharmaceutical R&D-offer biologically relevant
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce, Qlik Technologies, MicroStrategy Incorporated
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033. Business Analytics Market Overview The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,

All 5 Releases


More Releases for Pigmented

Pigmented Lesion Treatment Market Top Players Revenue and Forecasts Research
"The Pigmented Lesion Treatment Market, Insights, Size, Growth, Challenges, Opportunities, Emerging Trends, and Geographic Regions, Forecast Period: to Pigmented Lesion Treatment Market" The emergence of new diseases, such as COVID-19 (novel coronavirus), is expected to propel the Pigmented Lesion Treatment Market growth during the forecast period. According to the World Health Organization (WHO), new diseases have been emerging at the unprecedented rate of one a year for the last two decades,
Pigmented Concrete Market - Forecast to 2026
As per the research conducted by GME, the Pigmented Concrete Market will grow with a CAGR value of around 7 percent over the forecast period. Browse TOC on “Global Pigmented Concrete Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-pigmented-concrete-market-2739 By Type (Stained, Dyed, Paint, Tinted Sealers, Integral Colour, Dry Shake Colour Hardener), By Application (Walls, Floors, Driveways & Sidewalks, Pool Decks, Patios), By End-Use (Residential, Non-Residential), By Region (North America, Asia Pacific, Europe,
Global Pigmented Paper Market Outlook (2014-2025)
The report on the global Pigmented Paper market has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Pigmented Paper market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the
Pigmented Paper Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pigmented Paper Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Pigmented Paper players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Pigmented Paper with respect to individual growth
Pigmented Lesion Treatment Market – Worldwide Transformation Overview 2025 | L …
Global Pigmented Lesion Treatment Market: Overview The global market for pigmented lesion treatment is poised for a steady growth in the years ahead. Increasing prevalence of pigmented lesions is serving to drive the demand for its treatment worldwide. Pigmented lesions is a common skin condition among the geriatric population. Mostly visible on the face, it can be visible on other parts of the body as well. Extreme exposure to sun and aging
Pigmented Lesion Treatment Market – Development Assessment 2025 | Lutronic Cor …
Global Pigmented Lesion Treatment Market: Snapshot Often, pigmented lesions are difficult to be classified, which in turn escalates the possibilities of a melanoma diagnosis. Emphasis must be given on exercises that exclude benign melanocytic entities and non-melanocytic lesions, as both has the ability of mimicking melanoma. At the same time, considerations must be made for the lesion to be an epidermotropic metastasis or melanoma variant. Poikilormera, erythema, solar lentigo, broken capillaries,